Home > Insider Trading > Filing (0001562180-21-005865)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1770121	Sana Biotechnology Inc.	SANA	Biological Products, (No Disgnostic Substances) (2836)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1830070	Christian Hordo	C/O Sana Biotechnology, Inc. 188 East Blaine Street, Suite 400 Seattle WA 98102	Evp, Chief Business Officer	No	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2021-09-02	6,558	$1.48	977,356	No	4	M	Direct
Common Stock	Disposition	2021-09-02	6,558	$25.00	970,798	No	4	S	Direct
Common Stock	Disposition	2021-09-02	1,400	$25.00	969,398	No	4	S	Direct
Common Stock	Acquisiton	2021-09-03	700	$1.48	970,098	No	4	M	Direct
Common Stock	Disposition	2021-09-03	700	$25.00	969,398	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (Right to Buy)	Disposition	2021-09-02	6,558	$0.00	6,558	$1.48
Common Stock	Stock Option (Right to Buy)	Disposition	2021-09-03	700	$0.00	700	$1.48

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
128,708		2030-01-26	No	4	M	Direct
128,008		2030-01-26	No	4	M	Direct

Footnotes

The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 4, 2021.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $25.00 to $25.02, inclusive. The reporting person undertakes to provide to Sana Biotechnology, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (3) to this Form 4.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $25.00 to $25.015, inclusive.
This option began vesting on February 14, 2020, with 25% of the underlying shares becoming vested and exercisable on February 14, 2021 and the remainder of the underlying shares vesting at a rate of 1/36th per month thereafter.